Dawson James Securities Announces the Closing of Public Offering for Sigma Labs, Inc. for Gross Proceeds of $2,390,000
June 27 2018 - 5:10PM
Dawson James Securities, Inc. in conjunction with Sigma Labs, Inc.
(NASDAQ:SGLB) completed a registered direct offering of 2,390,000
units consisting of one share of common stock and 30% of a warrant
to purchase a share of common stock at a price of $1.00 per
unit. The warrants are immediately exercisable at a price of
$1.08 per share of common stock and will expire on the fifth
anniversary of the date of issuance. To the extent that the
purchase of shares of common stock would result in beneficial
ownership above 4.99%, an investor could elect to purchase shares
of the Company’s Series C Convertible Preferred Stock in lieu of
common stock. Each share of preferred stock has no dividend
rights. The offering closed on June 26th, 2018.
The Company intends to use the net proceeds from
the offering for general working capital and corporate
purposes. Dawson James Securities, Inc. acted as sole
placement agent for the offering.
The shares described above were offered by Sigma
Labs, Inc. pursuant to a registration statement on Form S-3
previously filed with, and subsequently declared effective by, the
Securities and Exchange Commission (“SEC”). A final prospectus
supplement relating to the offering was filed with the SEC and is
available, along with the accompanying base prospectus, on the
SEC's website at http://www.sec.gov, or by contacting Dawson
James: 1 N. Federal Hwy; Suite 500, Boca Raton, FL 33432
ATTN: Prospectus Department.
About Sigma Labs
Sigma Labs, Inc. is a provider of quality
assurance software under the PrintRite3D® brand and a developer of
advanced, in-process, non-destructive quality assurance software
for commercial firms worldwide seeking productive solutions for
advanced manufacturing. www.sigmalabsinc.com
About Dawson James
Securities
Dawson James Securities specializes in capital
raising for small and microcap public and private growth companies
primarily in the Life Science/Health Care, Technology and Consumer
sectors and is a full-service investment banking firm with
research, institutional and retail sales, and execution trading and
corporate services. Headquartered in Boca Raton, FL, Dawson
James is privately held with offices in New York, Maryland and New
Jersey. www.dawsonjames.com
Safe Harbor Statement
Safe Harbor Statement under the Private
Securities Litigation Reform Act of 1995: This news release
may contain forward-looking information within the meaning of
Section 27A Of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended, including
statements that include the words “believes”, “expects”,
“anticipates” or similar expressions. Such forward-looking
statements involve known and unknown risks, uncertainties and other
factors that may cause the actual results, performance or
achievements of the Company to differ materially from those
expressed or implied by such forward-looking
statements.
Member FINRA/SIPC. For more
information, please contact:
Elise Stern, Managing Director, Head of
Capital
Marketsestern@dawsonjames.com561-208-2926
Sigma Labs (NASDAQ:SGLB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sigma Labs (NASDAQ:SGLB)
Historical Stock Chart
From Apr 2023 to Apr 2024